指南与共识医学教育与科研方法临床试验与 GCP

临床研究中纳入患者报告结局的伦理考量:PRO伦理指南

Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines.
指南 / 共识 · JAMA · 2022-01-01

该指南由国际多学科团队依据EQUATOR框架制定,经系统综述、两轮国际德尔菲(96人)和共识会议(25人)形成14条推荐,涉及研究理由、目标、入组标准、PRO概念与域、评估时间表、样本量、数据监测、完成障碍、参与者可接受性与负担、问卷施测、患者伙伴参与、缺失数据及传播计划等伦理问题。

要点

  • PRO伦理指南共14条推荐,覆盖研究理由、目标、入组、PRO概念与域、评估时间表、样本量、数据监测等伦理议题。
  • 制定方法包括系统综述、两轮国际德尔菲(96名参与者)和共识会议(25名国际参与者)。
  • 指南旨在确保高质量PRO数据的同时最小化参与者风险、负担和伤害,并保护参与者和研究者福利。

核心结论

  • PRO伦理指南为PRO临床研究中应处理的伦理问题提供推荐,有望确保高质量PRO数据并最小化参与者风险、负担和伤害,保护参与者和研究者福利。

研究设计与样本

  • 遵循EQUATOR网络指南制定框架,包括系统综述(检索MEDLINE、Embase、AMED和CINAHL自建库至2020年3月)、SPIRIT-PRO扩展补充、两轮国际德尔菲(96名参与者,2021年5月和8月)及共识会议(25名国际参与者,2021年10月)。

主要发现

  • 第一轮德尔菲审议23个条目:6个来自系统综述的相关候选条目和17个来自SPIRIT-PRO扩展的附加条目。
  • 96名国际参与者投票,12个附加条目被推荐进入第二轮德尔菲(共35个条目)。
  • 共识会议(25名参与者)推荐纳入14个条目,最终措辞由共识会议参与者与6名额外人员输入后达成共识。

关键数值与推荐

  • 纳入条目聚焦PRO特异性伦理问题:研究理由、目标、入组要求、PRO概念与域、PRO评估时间表、样本量、PRO数据监测、PRO完成障碍、参与者可接受性与负担、无法自我报告PRO数据的参与者问卷施测、患者伙伴或公众成员对PRO策略的输入、避免缺失数据及传播计划。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patient-reported outcomes (PROs) can inform health care decisions, regulatory decisions, and health care policy. They also can be used for audit/benchmarking and monitoring symptoms to provide timely care tailored to individual needs. However, several ethical issues have been raised in relation to PRO use. OBJECTIVE: To develop international, consensus-based, PRO-specific ethical guidelines for clinical research. EVIDENCE REVIEW: The PRO ethics guidelines were developed following the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network's guideline development framework. This included a systematic review of the ethical implications of PROs in clinical research. The databases MEDLINE (Ovid), Embase, AMED, and CINAHL were searched from inception until March 2020. The keywords patient reported outcome* and ethic* were used to search the databases. Two reviewers independently conducted title and abstract screening before full-text screening to determine eligibility. The review was supplemented by the SPIRIT-PRO Extension recommendations for trial protocol. Subsequently, a 2-round international Delphi process (n = 96 participants; May and August 2021) and a consensus meeting (n = 25 international participants; October 2021) were held. Prior to voting, consensus meeting participants were provided with a summary of the Delphi process results and information on whether the items aligned with existing ethical guidance. FINDINGS: Twenty-three items were considered in the first round of the Delphi process: 6 relevant candidate items from the systematic review and 17 additional items drawn from the SPIRIT-PRO Extension. Ninety-six international participants voted on the relevant importance of each item for inclusion in ethical guidelines and 12 additional items were recommended for inclusion in round 2 of the Delphi (35 items in total). Fourteen items were recommended for inclusion at the consensus meeting (n = 25 participants). The final wording of the PRO ethical guidelines was agreed on by consensus meeting participants with input from 6 additional individuals. Included items focused on PRO-specific ethical issues relating to research rationale, objectives, eligibility requirements, PRO concepts and domains, PRO assessment schedules, sample size, PRO data monitoring, barriers to PRO completion, participant acceptability and burden, administration of PRO questionnaires for participants who are unable to self-report PRO data, input on PRO strategy by patient partners or members of the public, avoiding missing data, and dissemination plans. CONCLUSIONS AND RELEVANCE: The PRO ethics guidelines provide recommendations for ethical issues that should be addressed in PRO clinical research. Addressing ethical issues of PRO clinical research has the potential to ensure high-quality PRO data while minimizing participant risk, burden, and harm and protecting participant and researcher welfare.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Cruz Rivera S, Aiyegbusi OL, Ives J, et al. Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics Guidelines. JAMA. 2022. PMID: 35579638. doi:10.1001/jama.2022.6421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。